RAPID MICRO BIOSYSTEMS, INC. (RPID): debt financing — Rapid Micro Biosystems Q2 revenue $7.3M (+10% YoY); enters $45M term loan with Trinity Capital

RAPID MICRO BIOSYSTEMS, INC.

Q2 2025 revenue $7.3M, up 10% YoY; net loss $11.9M ($0.27/sh) vs $12.6M ($0.29) prior year.
Gross margin turned positive at 4% (vs -3% in Q2 2024); recurring revenue up 15% to $4.4M.
Reaffirms FY2025 revenue guidance of at least $32.0M.
Entered $45M term loan facility with Trinity Capital; $20M drawn at close, no financial covenants.
Initial interest rate 11.5% p.a.; 36-month interest-only period; warrants for 179,104 shares at $3.35/sh.

item 1.01 item 2.02 item 2.03 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

RAPID MICRO BIOSYSTEMS, INC. incurred term loan of $20.0 million with Trinity Capital Inc. at the greater of (a) the sum of (i) The Wall Street Journal Prime Rate and (ii) 4. maturing September 1, 2030.

Instrument: term loan
Principal: $20.0 million
Counterparty: Trinity Capital Inc.
Rate: the greater of (a) the sum of (i) The Wall Street Journal Prime Rate and (ii) 4.
Maturity: September 1, 2030
Event: incurrence

Exact text from the filing

On August 8, 2025 (the "Closing Date"), Rapid Micro Biosystems, Inc. (the "Company") entered into a Loan and Security Agreement (the "LSA") with the lenders party thereto (the "Lenders") and Trinity Capital Inc., as administrative agent and collateral agent (the "Agent"). Under the LSA, the Lenders agreed to extend debt capital to the Company, in the form of a term loan, in tranches totaling an aggregate principal amount of up to $45.0 million available as follows: (a) at closing, an aggregate principal amount of $20.0 million (the "First Tranche")

View on SEC.gov

90 debt financings filed in the last 30 days. Browse all debt financings →

RAPID MICRO BIOSYSTEMS, INC. filing history →

Source: SEC EDGAR

accession 0001380106-25-000169

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.